Refine
Year of publication
Document Type
- Article (79)
- Conference Proceeding (5)
- Part of a Book (2)
- Doctoral Thesis (2)
- Habilitation (2)
- Book (1)
Has Fulltext
- no (91) (remove)
Keywords
- Alzheimer's disease (1)
- Coefficient of ocular rigidity (1)
- Corneo-scleral shell (1)
- Differential tonometry (1)
- Endothelial dysfunction (1)
- Eyeball (1)
- Glaucoma (1)
- Haemodialysis (1)
- Long COVID (1)
- Machine learning (1)
- Microcirculation (1)
- Mild cognitive impairment (1)
- Myocardial infarction and cardiac death (1)
- Ocular blood flow (1)
- Post-COVID-19 syndrome (1)
- Pressure-volume relationship (1)
- Pulsations (1)
- RVA (1)
- Retinal vessel analysis (1)
- Retinal vessels (1)
- Vascular response (1)
- Vasomotions (1)
- Visual field asymmetry (1)
- cerebral small vessel disease (1)
- cognitive impairment (1)
- constructive alignment (1)
- dialysis (1)
- examination (1)
- long-term retention (1)
- multimodal (1)
- practical learning (1)
- retinal microvasculature (1)
- retinal vessels (1)
False spectra formation in the differential two-channel scheme of the laser Doppler flowmeter
(2018)
Noise in the differential two-channel scheme of a classic laser Doppler flowmetry (LDF) instrument was studied. Formation of false spectral components in the output signal due to beating of electrical signals in the differential amplifier was found out. The improved block-diagram of the flowmeter was developed allowing to reduce the noise.
Air-pulse corneal applanation signal curve parameters for the characterisation of keratoconus
(2011)
Aneurysmal subarachnoid hemorrhage (aSAH) is associated with early and delayed brain injury due to several underlying and interrelated processes, which include inflammation, oxidative stress, endothelial, and neuronal apoptosis. Treatment with melatonin, a cytoprotective neurohormone with anti-inflammatory, anti-oxidant and anti-apoptotic effects, has been shown to attenuate early brain injury (EBI) and to prevent delayed cerebral vasospasm in experimental aSAH models. Less is known about the role of endogenous melatonin for aSAH outcome and how its production is altered by the pathophysiological cascades initiated during EBI. In the present observational study, we analyzed changes in melatonin levels during the first three weeks after aSAH.